I. W. Reimann

Statistics

Publications

Citations

1.6K

H-Index

Active since

1973

Affiliations

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology(Current)

Robert Bosch (Germany)

Friedrich Schiller University Jena

Novartis (Germany)

Ludwig-Maximilians-Universität München

I. W. Reimann is an author at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology specializing in pharmacology, medicine, and clinical pharmacology.

Publications per year

1973–2001

Publications

Delayed Clearance of Diazepam Due to Cimetidine

Ulrich Klotz, I. W. Reimann · New England Journal of Medicine · 1980 · 337 citations

Medicine, Pharmacokinetics, Pharmacology +13

Opipramol for the Treatment of Generalized Anxiety Disorder: A Placebo-Controlled Trial Including an Alprazolam-Treated Group

Hans‐Jürgen Möller, Hans‐Peter Volz, I. W. Reimann et al. · Journal of Clinical Psychopharmacology · 2001 · 145 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pharmacokinetics of the selective benzodiazepine antagonist Ro 15-1788 in man

Ulrich Klotz, G. Ziegler, I. W. Reimann · European Journal of Clinical Pharmacology · 1984 · 133 citations

Medicine, Pharmacokinetics, Pharmacology +5

Effects of diclofenac on lithium kinetics

I. W. Reimann, Jürgen C. Frölich · Clinical Pharmacology & Therapeutics · 1981 · 98 citations

Medicine, Pharmacology, Pharmacotherapy +13

Opipramol for the treatment of somatoform disorders results from a placebo-controlled trial

Hans‐Peter Volz, Hans‐Jürgen Möller, I. W. Reimann et al. · European Neuropsychopharmacology · 2000 · 92 citations

Medicine, Pharmacology, Pharmacotherapy +8

1–5 of 25